Insulin resistance in clinical and experimental alcoholic liver disease - sprookjes - yvandenbroek - TriplyDB

Insulin resistance in clinical and experimental alcoholic liver disease

Insulin resistance in clinical and experimental alcoholic liver disease

http://www.wikidata.org/entity/Q26865988

about

Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort.A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.Circulating fibroblast growth factor 21 in patients with liver cirrhosis.Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells

P2860

Q40012493-5FA2C5FB-98E1-4955-90E8-7FF32FA91BAC Q42367659-4FBB649E-1987-41D5-AB3E-EF72EFFD801C Q47179866-E6DA0CCA-E3AC-4923-8837-5D4DA1C0ADB5 Q47780310-342E3569-E197-428B-8A1F-EA3B410A1CEB Q48027127-43920DC6-B8B2-49F5-BDB0-E549BE268C8B Q57192818-523EAB78-29EB-4092-8096-C5394BAF2AF7 Q58701278-26BC5259-9712-4692-A944-F658BE6BCC6E

P2860

Insulin resistance in clinical and experimental alcoholic liver disease

http://www.wikidata.org/entity/Q26865988

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Insulin resistance in clinical and experimental alcoholic liver disease

@ast

Insulin resistance in clinical and experimental alcoholic liver disease

@en

Insulin resistance in clinical and experimental alcoholic liver disease

@nl

type

label

Insulin resistance in clinical and experimental alcoholic liver disease

@ast

Insulin resistance in clinical and experimental alcoholic liver disease

@en

Insulin resistance in clinical and experimental alcoholic liver disease

@nl

prefLabel

Insulin resistance in clinical and experimental alcoholic liver disease

@ast

Insulin resistance in clinical and experimental alcoholic liver disease

@en

Insulin resistance in clinical and experimental alcoholic liver disease

@nl

P1433

Q26865988-A6B81845-B5DB-4F91-A75A-7EB761305FA0

P1476

Q26865988-9C686B42-1345-4ABC-BF09-AA08290D3B87

P2093

Q26865988-01464A39-1A30-4CD3-AEF4-8B6286ACD532

Q26865988-9BB60CC0-A5AC-479E-BC25-E781EE260621

P2860

Q26865988-0173F8AF-00A8-4624-8207-B23F0C8775F7

Q26865988-03FF81D0-6BCD-4FC1-9FFC-2550DD6B7EBE

Q26865988-04602B94-6BAD-4106-9060-E39B43BDEBC3

Q26865988-0A2EEC7F-22E9-4C07-9EA0-F43A1836B7EE

Q26865988-0BA5ABD6-E49A-4726-8BD7-3A1136C194DF

Q26865988-0D2316CE-728D-4F71-B367-1E42C1CED4B4

Q26865988-0D423D35-0E67-47C1-95E5-438EA89C36FB

Q26865988-0D7BA78E-DB23-4C7F-BC9A-05280E07DF76

Q26865988-0DF2FD69-193B-4233-8972-855FFEEBBCE6

Q26865988-0EA17E63-5FAD-4038-837B-8BBCA61EB135

P304

Q26865988-01F56D21-F799-42DE-BE9F-CE447E67E530

P31

Q26865988-287A8694-0EB7-495A-B251-2E71B1312596

P356

Q26865988-9F386755-6DC4-4907-A9B6-CFA7FDA55365

P407

Q26865988-99818FE4-DAF0-480A-BAAF-C9D91ECDC7F4

P478

Q26865988-CA216E8F-9952-42C6-9909-B9F9DFA0E54E

P577

Q26865988-5A4C93B3-3DC2-4E84-803B-2C0D657A6416

P698

Q26865988-B9EFB878-944B-4AF7-B76D-F0DC90DA0950

P921

Q26865988-69268E3E-9482-441F-AF39-D8999F6B6471

P932

Q26865988-DA61471B-5DFB-4181-9D26-10D140C6E1E8

P356

P1433

Annals of the New York Academy of Sciences

P1476

Insulin resistance in clinical and experimental alcoholic liver disease

@en

P2093

Jason Correnti

http://www.w3.org/2001/XMLSchema#string

Rotonya M. Carr

http://www.w3.org/2001/XMLSchema#string

P2860

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis

Selection of the appropriate method for the assessment of insulin resistance

Alcoholic liver disease: pathogenesis and new therapeutic targets.

Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice

Characterization of the human patatin-like phospholipase family

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Acetaldehyde enhances murine alpha2(I) collagen promoter activity by Ca2+-independent protein kinase C activation in cultured rat hepatic stellate cells

P304

1-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NYAS.12787

http://www.w3.org/2001/XMLSchema#string

P407

P478

1353

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25998863

http://www.w3.org/2001/XMLSchema#string

P921

P932

4623941

http://www.w3.org/2001/XMLSchema#string